Literature DB >> 15069461

Genetic polymorphisms of the beta-adrenergic system: association with essential hypertension and response to beta-blockade.

F Filigheddu1, J E Reid, C Troffa, P PinnaParpaglia, G Argiolas, A Testa, M Skolnick, N Glorioso.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15069461     DOI: 10.1038/sj.tpj.6500247

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


× No keyword cloud information.
  16 in total

1.  β-AR polymorphisms and glycemic and lipid parameters in hypertensive individuals receiving carvedilol or metoprolol.

Authors:  Orly Vardeny; Gabriel Nicholas; Alina Andrei; Kevin A Buhr; Matt P Hermanson; John J Moran; Michelle A Detry; James H Stein
Journal:  Am J Hypertens       Date:  2012-05-31       Impact factor: 2.689

Review 2.  Pharmacogenetics of beta-blockers.

Authors:  Jaekyu Shin; Julie A Johnson
Journal:  Pharmacotherapy       Date:  2007-06       Impact factor: 4.705

3.  Synopsis and data synthesis of genetic association studies in hypertension for the adrenergic receptor family genes: the CUMAGAS-HYPERT database.

Authors:  Georgios D Kitsios; Elias Zintzaras
Journal:  Am J Hypertens       Date:  2009-12-31       Impact factor: 2.689

4.  The β1-adrenoreceptor gene Arg389Gly and Ser49Gly polymorphisms and hypertension: a meta-analysis.

Authors:  Hong Kong; Xiaobo Li; Shanshan Zhang; Shujie Guo; Wenquan Niu
Journal:  Mol Biol Rep       Date:  2012-12-28       Impact factor: 2.316

5.  β-blocker therapy and heart rate control during exercise testing in the general population: role of a common G-protein β-3 subunit variant.

Authors:  Marcus Dörr; Carsten O Schmidt; Thomas Spielhagen; Alexa Bornhorst; Katharina Hentschel; Christina Franz; Klaus Empen; Thomas Kocher; Scott R Diehl; Heyo K Kroemer; Henry Völzke; Ralf Ewert; Stephan B Felix; Dieter Rosskopf
Journal:  Pharmacogenomics       Date:  2010-09       Impact factor: 2.533

6.  β2 adrenergic receptor polymorphisms and nocturnal blood pressure dipping status in the Wisconsin Sleep Cohort Study.

Authors:  Orly Vardeny; Paul E Peppard; Laurel A Finn; Juliette H Faraco; Emmanuel Mignot; Khin Mae Hla
Journal:  J Am Soc Hypertens       Date:  2011 Mar-Apr

Review 7.  Pharmacogenetics of antihypertensive treatment: detailing disciplinary dissonance.

Authors:  Donna K Arnett; Steven A Claas
Journal:  Pharmacogenomics       Date:  2009-08       Impact factor: 2.533

8.  IFNG genotype and sex interact to influence the risk of childhood asthma.

Authors:  Dagan A Loisel; Zheng Tan; Christopher J Tisler; Michael D Evans; Ronald E Gangnon; Daniel J Jackson; James E Gern; Robert F Lemanske; Carole Ober
Journal:  J Allergy Clin Immunol       Date:  2011-07-27       Impact factor: 10.793

9.  β1-adrenoceptor gene Arg389Gly polymorphism and essential hypertension risk in general population: a meta-analysis.

Authors:  Hao Wang; Jielin Liu; Kuo Liu; Ya Liu; Zuoguang Wang; Yuqing Lou; Qiuli Niu; Wei Gu; Lijuan Wang; Mei Li; Xiaoling Zhu; Shaojun Wen
Journal:  Mol Biol Rep       Date:  2013-04-16       Impact factor: 2.316

10.  Relationship between the single nucleotide polymorphisms of β₂-adrenergic receptor 5'-regulatory region and essential hypertension in Chinese Kazakh ethnic minority group.

Authors:  Weijuan Cai; Liang Yin; Jiang Cheng; Shaoliang Wang; Yu Wei; Wenjiang Cao; Jiang Cheng
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.